Publications by authors named "Hodgson Fraser"
Article Synopsis
- The study investigates the prevalence of invasive cancers in a general practice patient population in New Zealand, finding 206 cancer diagnoses among 201 patients from 2009 to 2018, with notable figures in both Māori and non-Māori groups.
- Results indicate higher age-standardised cancer prevalence in Māori patients (3092/100,000) compared to non-Māori patients (1971/100,000), with the most common types being breast, male genital organ, digestive organ, and skin cancers.
- The findings highlight that a significant portion (40.8%) of cancer patients received only primary care from general practitioners, with prevalent comorbidities like hypertension and mood disorders,
Introduction: Approximately 350 000 prostate-specific antigen (PSA) tests are undertaken in New Zealand on a quarter of a million men each year. A number of studies have looked at PSA testing done by general practitioners (GPs) and subsequent outcomes. Few have looked at the patient perspective after a raised PSA result.
View Article and Find Full Text PDFPurpose: To examine prostate-specific antigen (PSA) screening patterns and outcomes in rural and urban men in New Zealand.
Methods: Men aged 40+ years were identified from 18 rural and 13 urban general practices across the Midland Cancer Network region. Computerized practice records were cross-referenced with community laboratory data to ascertain the number and level of PSA tests undertaken in 2010 and 3 years prior.
Background: Māori men in New Zealand have higher mortality from prostate cancer, despite having lower incidence rates. The objective of this study was to examine patterns of screening for prostate cancer in primary care and follow-up investigations after an elevated prostate-specific antigen (PSA) result in Māori and non-Māori men in order to help explain the observed differences in incidence and mortality.
Methods: Men aged 40+ years were identified from 31 general practices across the Midland Cancer Network region.
Background: Screening for prostate cancer (PCa) using the prostate-specific antigen (PSA) test is widespread in New Zealand. Aim. This study estimates the costs of identifying a new case of PCa by screening asymptomatic men.
View Article and Find Full Text PDFObjective: To ascertain the rates and patterns of prostate-specific antigen (PSA) screening in New Zealand men.
Methods: The study population included 35,958 men aged 40+ years, with no prior diagnosis of prostate cancer, enrolled in 31 general practices in the Midland Cancer Network Region of New Zealand in 2010. Computerized practice records were searched for information, including reasons for testing, for men with elevated PSA test results in 2010.
Introduction: In New Zealand, prostate-specific antigen (PSA) testing has increased significantly (275 000 tests/year). Controversy exists around PSA testing as part of an unorganised screening programme.
Aim: To look at the use of PSA testing in a sample of general practices and investigate the reasons GPs undertake PSA testing.